The "secret" of the moon cake"
Release time:
2021-09-22
Mid-Autumn Festival is a traditional folk festival. It has been passed down for thousands of years. It is a strong yearning from generation to generation. It is also a unique charm that a nation has experienced in the process of appreciating and tasting the moon. In this festival, people like to bring Mid-Autumn Festival mooncakes to visit relatives and friends to exchange homesickness and reunion.
After the Mid-Autumn Festival every year, many families will have some endless moon cakes left. In order not to waste, they rack their brains every day to try to finish the moon cakes. However, moon cakes contain high fat and high sugar. Many people eat too many moon cakes, which will cause indigestion, increase blood sugar due to excessive calories, hypertension, obesity, and elevated blood lipids. So, how should we eat mooncakes with a reasonable mix in order to eat healthy mooncakes?
First of all, we should choose varieties skillfully, should choose thin skin, stuffing with sesame, hawthorn-based, to help digestion of mooncakes. Even moon cakes marked "sugar-free " should be noted that sugar alcohol is usually used as a sweet substitute, and not everyone's stomach can adapt to sugar alcohol.
Secondly, the moon cake should be divided into pieces and eaten several times in small quantities. Once you eat more moon cakes, you can take mild fire-reducing drugs such as Kouyanqing Granules. Try not to eat moon cakes for breakfast or dinner. It is best to eat them after a meal or on a semi-empty stomach.
Finally, pay attention to diet collocation, make a cup of black tea, scented tea, or Pu 'er tea, plain boiled water can also be drunk when the water temperature is hot, which is helpful to eliminate food and lead to stagnation.
Of course, in addition to choosing products from regular manufacturers, checking the production date and shelf life, and checking whether the packaging is complete, it is more important to control the amount of food eaten according to their own health conditions, especially for the elderly suffering from diseases such as "Three Highs " .
I hope people will live for a long time and live together for thousands of miles. The Mid-Autumn Festival is coming soon. I wish the festival more good luck and a full moon! (Yang Shunchang)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31